Understanding Racial Disparities in HIV Using Data from the Veterans Aging Cohort 3-Site Study and VA Administrative Data

American Journal of Public Health

Volumn 93, Issue 10, 2003, Pages 1728-1733

  McGinnis, Kathleen A ^a,b   Fine, Michael J ^b,c   Sharma, Ravi K ^d   Skanderson, Melissa ^a,b   Wagner, Joseph H ^a,b   Rodriguez Barradas, Maria C ^a   Rabeneck, Linda ^a,e   Justice, Amy C ^a,b,c,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VA Ctr for Hlth Equity Res/Prom   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; MORTALITY; PATIENT COMPLIANCE; RACE DIFFERENCE; SOLDIER; SURVIVAL; TREATMENT OUTCOME; AFRICAN AMERICAN; CAUCASIAN; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE MANAGEMENT; ETHNOLOGY; GOVERNMENT; HISPANIC; MIDDLE AGED; PATIENT ATTITUDE; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGICAL ASPECT; SOCIOECONOMICS; STATISTICS; UNITED STATES; UTILIZATION REVIEW; VETERAN;

ADULT; AFRICAN AMERICANS; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DISEASE MANAGEMENT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 0642345349     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.93.10.1728     Document Type: Article

References (17)

1. The National Initiative to Eliminate Racial and Ethnic Disparities in Health: An Overview, Bethesda, Md: US Dept of Health and Human Services; 2001. Available at http://raceandhealth.hhs.gov. Accessed May 29, 2000.
2. Conigliaro J, Whittle J, Good CB, Skanderson M, Kelley M, Goldberg K. Delay in presentation for cardiac care by race, age, and site of care. Med Care. 2002;40(1 suppl):I97-I105.
3. Ashton CM, Peterson NJ, Wray NP, Yu HJ. The Veterans Affairs medical care system: hospital and clinic utilization statistics for 1994. Med Care. 1998;36:793-803.
4. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999;281:2305-2315.
5. Fasciano NJ, Cherlow AL, Turner BJ, Thornton CV. Profile of Medicare beneficiaries with AIDS: application of an AIDS casefinding algorithm. Health Care Financing Rev. 1998;19:19-38.
6. Fisher SG, Weber L, Goldberg J, Davis F. Mortality ascertainment in the veteran population: alternatives to the National Death Index. Am J Epidemiol. 1995;141:242-250.
7. Justice AC, Landefeld CS, Asch SM, Gifford AL, Whalen CC, Covinsky KE. Justification for a new cohort study of people aging with and without HIV infection. J Clin Epidemiol. 2001;54(suppl 1):S3-S8.
8. Smola S, Justice AC, Wagner J, Rabeneck L, Weissman S, Rodriguez-Barradas M. Veterans aging cohort three-site study (VACS 3): overview and description. J Clin Epidemiol. 2001;54(suppl 1):S61-S76.
9. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK, Panel on Clinical Practices for the Treatment of HIV. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recomm Rep. 2002;51(RR-7):1-55.
10. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12:255-266.
11. Jha AK, Shlipak MG, Hosmer W, Frances CD, Browner WS. Racial differences in mortality among men hospitalized in the Veterans Affairs health care system. JAMA. 2001;285:297-303.
12. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119-129.
13. Palella FJ Jr, Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138:620-626.
14. Ory M, Mack K. HIV/AIDS rates and trends among middle aged and older individuals. JAIDS. In press.
15. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516-1520.
16. Harada ND, Damron-Rodriguez J, Villa VM, et al. Veteran identity and race/ethnicity: influences on VA outpatient care utilization. Med Care. 2002;40(1 suppl):I117-I128.
17. Boehmer U, Kressin NR, Berlowitz DR, Christiansen CL, Kazis LE, Jones JA. Self-reported vs administrative race/ethnicity data and study results. Am J Public Health. 2002;92:1471-1472.